Correspondence 0001104659-24-125470 from Marker Therapeutics, Inc. (MRKR) (CIK 0001094038) (MRKR)

Marker Therapeutics, Inc. (MRKR) (CIK 0001094038)
Date: Dec. 4, 2024 · CIK: 0001094038 · Accession: 0001104659-24-125470

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-283512

Date

December 4, 2024

Author

/s/ Juan Vera

Form

CORRESP

Company

Marker Therapeutics, Inc. (MRKR) (CIK 0001094038)

Letter

VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Re: Marker Therapeutics, Inc. (the “Company”) Registration Statement on Form S-3 File No. 333-283512 Request for Acceleration

Dear Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) respectfully requests that the Securities and Exchange Commission take appropriate action to cause the above referenced Registration Statement on Form S-3 (the “Registration Statement”) to be declared effective at 4:00 p.m., Eastern Time, on Friday, December 6, 2024, or as soon thereafter as is practicable.

Once the Registration Statement has been declared effective, please orally confirm that event with Mark Catchur of Shumaker, Loop & Kendrick, LLP at (813) 227-2264. Thank you for your assistance in this matter.

Very truly yours,
By:
/s/ Juan Vera

Show Raw Text

CORRESP
1
filename1.htm

December 4, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3628

Attn: Jason Drory

 Re: Marker Therapeutics, Inc. (the “Company”)

Registration Statement on Form S-3

File No. 333-283512

Request for Acceleration

Dear Ladies and Gentlemen:

In accordance with Rule 461
under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) respectfully requests that
the Securities and Exchange Commission take appropriate action to cause the above referenced Registration Statement on Form S-3 (the “Registration
Statement”) to be declared effective at 4:00 p.m., Eastern Time, on Friday, December 6, 2024, or as soon thereafter as is practicable.

Once the Registration Statement
has been declared effective, please orally confirm that event with Mark Catchur of Shumaker, Loop & Kendrick, LLP at (813)
227-2264. Thank you for your assistance in this matter.

    Very truly yours,

    By:
    /s/ Juan Vera

    Juan Vera

    President and Chief Executive Officer

cc: Mark A. Catchur, Shumaker, Loop & Kendrick, LLP

    Marker Therapeutics, Inc.

2450 Holcombe Blvd., Suite BCM-A, MS: BCM251, Houston, TX 77021

SecProbe.io